首页> 外文会议>International Congress on Coronary Artery Disease >Undertreatment of hypercholesterolemia in Bulgaria in primary and secondary prevention setting - the CEPHEUS experience
【24h】

Undertreatment of hypercholesterolemia in Bulgaria in primary and secondary prevention setting - the CEPHEUS experience

机译:保加利亚在初级和二级预防环境中的高胆固醇血症患者 - Cepheus经验

获取原文

摘要

The aim of the CEPHEUS study was to establish the proportion of patients in Bulgaria taking lipid-lowering drugs (LLDs) who reached the LDL-C goals according to the existing guidelines - the FJETF, the NCEP ATP III and 2004 updated NCEP ATP III. Overall, 43.1% patients were at the target LDL-C goals as recommended by the FJETF. According NCEP 2001 guidelines 45.24% and according the updated NCEP guidelines 2004 only 21.51% of the patients have reached the target resp. The results of this survey highlight the fact that there is significant treatment gap in hypercholesterolemia management in Bulgarian patients receiving LLD.
机译:Cepheus研究的目的是建立保加利亚患者的比例服用降脂药物(LLD)根据现有的指导方针 - FJETF,NCEP ATP III和2004年更新的NCEP ATP III。 总体而言,43.1%的患者按照FJETF推荐的目标LDL-C目标。 根据NCEP 2001指南45.24%,并根据更新的NCEP指南2004年,只有21.51%的患者达到了目标。 该调查的结果强调了保加利亚患者的高胆固醇血症管理中存在显着治疗差距。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号